Polypharmacy in patients hospitalised for acute exacerbation of COPD

European Respiratory Journal

Volumn 44, Issue 3, 2014, Pages 791-794

  Díez Manglano, Jesús ^a,b   Barquero Romero, José ^c   Mena, Pedro Almagro ^d   Recio Iglesias, Jesús ^e   Cabrera Aguilar, Javier ^f   López García, Francisco ^g   Viu, Ramón Boixeda ^h   Soriano, Joan B ⁱ  

^a HOSPITAL ROYO VILLANOVA   (Spain)

^b INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

^c Hospital Tierra de Barros   (Spain)

^d HOSPITAL MÚTUA DE TERRASSA   (Spain)

^e HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g HOSPITAL VEGA BAJA   (Spain)

^h HOSPITAL DE MATARÓ   (Spain)

ⁱ Fundacion Caubet Cimera   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIURETIC AGENT; LONG ACTING DRUG; PROTON PUMP INHIBITOR;

AGE; AGED; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LETTER; LUNG INSUFFICIENCY; MAJOR CLINICAL STUDY; MALE; POLYPHARMACY; PREVALENCE; PRIORITY JOURNAL; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DISEASE COURSE; HOSPITAL ADMISSION; HOSPITALIZATION; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

AGED; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; POLYPHARMACY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TREATMENT OUTCOME;

EID: 84907350732     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00014814     Document Type: Letter

References (15)

1. Nielsen R, Johannessen A, Benediktsdottir B, et al. Present and future cost of COPD in Iceland and Norway: results of the BOLD study. Eur Respir J 2009; 34: 850-857.
2. Jakobsen M, Anker N, Dollerup J, et al. Study on drug costs associated with COPD prescription medicine in Denmark. Clin Respir J 2013; 7: 328-337.
3. Blanchette CM, Dalal AA, Mapel D. Changes in COPD demographics and costs over 20 years. J Med Econ 2012; 15: 1176-1182.
4. Corsonello A, Pedone C, Corica F, et al. Polypharmacy in elderly patients at discharge from the acute care hospital. Ther Clin Risk Manag 2007; 3: 197-203.
5. Hajjar ER, Hanlon JT, Artz MB, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003; 1: 82-89.
6. Gellad WF, Grenard JL, Marcum ZA. A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity. Am J Geriatr Pharmacother 2011; 9: 11-23.
7. Hovstadius B, Åstrand B, Persson U, et al. Acquisition cost of dispensed drugs in individuals with multiple medications - a register-based study in Sweden. Health Policy 2011; 101: 153-161.
8. Almagro P, López García F, Cabrera FJ, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010; 104: 253-259.
9. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
10. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother 2007; 5: 345-351.
11. Nobili A, Marengoni A, Tettamanti M, et al. Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. Eur J Intern Med 2011; 22: 597-602.
12. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004; 351: 2870-2874.
13. Travers J, Marsh S, Caldwell B, et al. External validity of randomized controlled trials in COPD. Respir Med 2007; 101: 1313-1320.
14. Holmes HM. Rational prescribing for patients with a reduced life expectancy. Clin Pharmacol Ther 2009; 85: 103-107.
15. Cook DE, Sidel M, Belletti DA, et al. Review: clinical inertia in the management of chronic obstructive pulmonary disease. COPD 2012; 9: 73-80.